We are live on ! Find out more
ERNA icon

Ernexa Therapeutics

3 hedge funds and large institutions have $1.84M invested in Ernexa Therapeutics in 2013 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

0.16% less ownership

Funds ownership: 7.43% → 7.26% (-0.16%)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $12K

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$12K

ERNA Hedge Fund Activity: Q3 2013 in Review

3 of the 3,095 institutional investors tracked by Wall St. Rank reported a position in Ernexa Therapeutics (ERNA) for Q3 2013, worth a combined $1.84M — down 15% from $2.18M a quarter earlier.

Fund positioning in ERNA was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Citadel Advisors, cutting an estimated $12K.

  • 3 institutional investors held Ernexa Therapeutics (ERNA) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $1.84M of Ernexa Therapeutics stock for Q3 2013, down 15% quarter-over-quarter.
  • 0 funds opened new Ernexa Therapeutics positions in Q3 2013 and 0 closed out.
  • The largest Ernexa Therapeutics seller in Q3 2013 was Citadel Advisors, an estimated $12K sold.

Based on aggregated 13F filings for Q3 2013.